X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
IPCA Labs Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Quarterly Results   (IPLB)

Here are the latest quarterly results of IPCA Labs. For more details, see the IPCA Labs financial fact sheet and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

IPCA Labs Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
3
Dec-16
3
Mar-17
*
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
8-Qtr Chart
Click to enlarge
Net Sales Rs m8,8517,5076,6587,1308,6438,5927,8288,539 
Other income Rs m62595262110110114136 
Turnover Rs m8,9137,5676,7107,1918,7538,7027,9418,676 
Expenses Rs m7,4926,4435,9816,9147,1536,9806,7297,399 
Gross profit Rs m1,3581,0656772151,4901,6121,0991,140 
Depreciation Rs m429432428433441438432445 
Interest Rs m6857445664566549 
Profit before tax Rs m924636257-2121,0961,228717782 
Tax Rs m374222-187-10131172204127 
Profit after tax Rs m550414444-2039651,056513655 
Gross profit margin %15.314.210.23.017.218.814.013.4 
Effective tax rate %40.534.9-72.74.612.014.028.416.2 
Net profit margin %6.25.56.7-2.811.212.36.67.7 
Diluted EPS Rs 4.4 3.3 3.5 -1.6 7.6 8.4 4.1 5.2  
Diluted EPS (TTM) Rs 10.5 11.9 14.9 9.5 12.8 17.9 18.5 25.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: IPCA Labs 1QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   TTK HEALTHCARE  STRIDES SHASUN LTD  MERCK LTD  WYETH LTD  SANOFI INDIA  

Compare IPCA LABS With:   TTK HEALTHCARE  STRIDES SHASUN LTD  MERCK LTD  WYETH LTD  SANOFI INDIA  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 383 Points Lower; Realty and Auto Stocks Drag(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Views on news

IPCA LABS Announces Quarterly Results (1QFY19); Net Profit Down 423.6% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, IPCA LABS has posted a net profit of Rs 655 m (down 423.6% YoY). Sales on the other hand came in at Rs 9 bn (up 19.8% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (4QFY18); Net Profit Up 15.6% (Quarterly Result Update)

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, IPCA LABS has posted a net profit of Rs 513 m (up 15.6% YoY). Sales on the other hand came in at Rs 8 bn (up 17.6% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

This Market Crash could be the Biggest Wealth Creating Opportunity Since 2008(Profit Hunter)

Oct 8, 2018

While widespread fear is the friend of a value investor, serving up bargain purchases; personal fear is an investor's biggest enemy.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Are These Deep Corrections a Buying Signal?(Chart Of The Day)

Oct 5, 2018

The correction has bought many good companies to reasonable valuations. Go against the wisdom of crowd and Buy.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Oct 17, 2018 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - SHASUN PHARMA COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS